Messenger RNA technology offers a faster way to develop vaccines to address or prepare for pandemics, and Moderna’s vaccine ...

Outbreaks of bird flu in mammals more than doubled across the world last year, raising the risk that the virus could ...

Highly pathogenic avian influenza viruses like H5N1, H5N6, and H7N9 pose an evolving global threat due to their capacity to ...

Highly pathogenic avian influenza reached Antarctica’s mainland in early 2024, leaving Australia, New Zealand and Pacific ...

Outbreaks of bird flu in mammals more than doubled across the world last year, raising the risk that the virus could ...

Outbreaks of highly pathogenic avian influenza more than doubled in mammals in 2024 from the year before, according to the a ...

In a major policy reversal, the U.S. Department of Health and Human Services (HHS) has canceled a $590 million agreement with ...

The award from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and ...

The Department of Health and Human Service is pulling millions of dollars in funding for a human bird flu vaccine developed ...

The bird flu virus remains a wild card that continues to threaten U.S. poultry and egg supplies while upping the ante with risk to human health.

It showed that the reported number of avian influenza outbreaks in mammals more than doubled last year compared to 2023 ...

MRNA technology is already used in Moderna’s and Pfizer/BioNTech’s currently licensed COVID-19 vaccines, which have been ...